Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: LUNA LABS USA LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-02-05 to 2027-06-04
Current total value of award: $1299999.31
Description: DHA STTR PHASE II PROPOSAL H2-0804, TITLED "SHELF-STABLE ANTIBIOTIC HYBRID EXOSOMES FOR THE TOPICAL TREATMENT OF WOUND INFECTIONS", MEDICAL R&D CONTRACT.